3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
20
Myelodysplastic Syndromes
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Hodgkin Disease
6
Myeloproliferative Disorders
5
Leukemia, Biphenotypic, Acute
5
Burkitt Lymphoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Recurrence
3
Neuroblastoma
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hematologic Neoplasms
2
Transplant-Related Hematologic Malignancy
1
Teratoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Primary Myelofibrosis
1
Neoplasms by Histologic Type
1
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Interventions
Bevacizumab
39
Paclitaxel
34
pembrolizumab
27
Carboplatin
26
Specimen Handling
21
olaparib
19
Magnetic Resonance Spectroscopy
19
Gemcitabine
18
liposomal doxorubicin
16
Cyclophosphamide
16
niraparib
13
fludarabine
12
Topotecan
12
Biopsy
12
Cisplatin
11
Taxes
8
Nivolumab
8
Immunoglobulin G
8
Fulvestrant
8
Disulfides
8
Surveys and Questionnaires
7
Doxorubicin
7
palbociclib
6
aldesleukin
6
Oxaliplatin
6
Letrozole
5
Fluorouracil
5
trastuzumab deruxtecan
4
oregovomab
4
mirvetuximab soravtansine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Granulocyte Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.